meglumine antimoniate has been researched along with Kidney Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daza González, MA; Fermín Rodríguez, M; Fragío Arnold, C; Miró, G; Rupérez Noguer, C | 1 |
| Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB | 1 |
| Cerón, JJ; Garcia-Martinez, JD; Martínez-Subiela, S; Pardo-Marín, L; Pastor, J; Segarra, S; Tvarijonaviciute, A | 1 |
| Aresu, L; Bianciardi, P; Brovida, C; Castagnaro, M; Cavicchioli, L; Giroud, L; Valente, M; Vischer, C | 1 |
| Abreu, KL; Daher, EF; Franco, LF; Garcia, AV; Libório, AB; Mota, RM; Oliveira, MJ; Rocha, NA; Silva Júnior, GB | 1 |
| Andrade, LC; Daher, EF; Junior, GB; Libório, AB; Lima, CG; Martins, AM; Mota, RM; Oliveira, RA; Sanches, TR; Seguro, AC | 1 |
| de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP | 1 |
| Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER | 1 |
8 other study(ies) available for meglumine antimoniate and Kidney Diseases
| Article | Year |
|---|---|
Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; Creatinine; Dog Diseases; Dogs; Female; Glomerular Filtration Rate; Kidney Diseases; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine Antimoniate | 2019 |
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2014 |
Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment.
Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Drug Therapy, Combination; Kidney Diseases; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteinuria | 2017 |
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytochemistry; Kidney; Kidney Diseases; Kidney Tubules; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Phosphorylcholine; Random Allocation; Toxicity Tests | 2009 |
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Kidney Diseases; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Young Adult | 2010 |
Renal function evaluation in patients with American cutaneous leishmaniasis after specific treatment with pentavalent antimonial.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Kidney; Kidney Diseases; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1983 |